Rare diseases
Investigational molecules
Locations
Heidelberglaan 25, 3584 CS Utrecht, The Netherlands
Research activity includes acute myeloid leukemia, acute lymphoblastic leukemia, B-cell acute lymphoblastic leukemia, mixed phenotype acute leukemia, and relapsed or refractory T-cell and B-cell lymphoblastic lymphoma. The portfolio also covers infant leukemia, FLT3-ITD-positive AML, KMT2A-rearranged ALL, and molecularly defined subgroups of pediatric hematologic malignancies.
Interest extends to CAR T-cell therapy, molecularly guided treatment, WT1-directed vaccination, and infection prophylaxis in children with leukemia.
Princess Maxima Center For Pediatric Oncology runs clinical trials in conditions such as Acute myeloid leukaemia, Acute lymphocytic leukaemia, Neuroblastoma, Precursor B-lymphoblastic lymphoma recurrent, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Austria
GermanyThe NetherlandsAustria
BelgiumThe NetherlandsAustriaAustriaAustriaAustriaAustriaBelgiumIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
